APA (7th ed.) Citation

PJ, C., R, T., R, K., ES, d. L., A, D., MK, R., . . . A, V. (2018). Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. Nature communications, 9, 16187. https://doi.org/10.1038/ncomms16187

Chicago Style (17th ed.) Citation

PJ, Cook, Thomas R, Kannan R, de Leon ES, Drilon A, Rosenblum MK, Scaltriti M, Benezra R, and Ventura A. "Author Correction: Somatic Chromosomal Engineering Identifies BCAN-NTRK1 as a Potent Glioma Driver and Therapeutic Target." Nature Communications 9 (2018): 16187. https://doi.org/10.1038/ncomms16187.

MLA (9th ed.) Citation

PJ, Cook, et al. "Author Correction: Somatic Chromosomal Engineering Identifies BCAN-NTRK1 as a Potent Glioma Driver and Therapeutic Target." Nature Communications, vol. 9, 2018, p. 16187, https://doi.org/10.1038/ncomms16187.